Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Martinez

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Nature|June 9, 2021
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humansGalit Alter, Jingyou Yu, Jinyan Liu, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesAmin Addetia, Alexandra Schäfer, Kaitlin Sprouse, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Nature|November 18, 2021
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccineMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
Cell Reports|July 16, 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Iscience|July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domainsChuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH DomainsChuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in miceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Nature|June 9, 2021
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humansGalit Alter, Jingyou Yu, Jinyan Liu, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesAmin Addetia, Alexandra Schäfer, Kaitlin Sprouse, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Nature|November 18, 2021
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccineMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
Cell Reports|July 16, 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Iscience|July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domainsChuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH DomainsChuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in miceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Pageof 12